Cullen/Frost Bankers Inc
NYSE:CFR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullen/Frost Bankers Inc
NYSE:CFR
|
US |
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
|
R
|
Realogy Holdings Corp
F:04M
|
US |
|
P
|
Priti International Ltd
NSE:PRITI
|
IN |
|
Nomura Real Estate Holdings Inc
TSE:3231
|
JP |
|
W
|
Westag AG
F:WUG
|
DE |
Wall Street
Price Targets
CFR Price Targets Summary
Cullen/Frost Bankers Inc
According to Wall Street analysts, the average 1-year price target for
CFR
is 150.96 USD
with a low forecast of 111.1 USD and a high forecast of 171.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CFR's stock price target?
Price Target
150.96
USD
According to Wall Street analysts, the average 1-year price target for
CFR
is 150.96 USD
with a low forecast of 111.1 USD and a high forecast of 171.15 USD.
What is Cullen/Frost Bankers Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Cullen/Frost Bankers Inc's revenue is
7%.
The projected
CAGR
for the next 3 years is
5%.
What is Cullen/Frost Bankers Inc's Net Income forecast?
Projected CAGR
2%
For the last 14 years the
compound annual growth rate for
Cullen/Frost Bankers Inc's net income is
8%.
The projected
CAGR
for the next 3 years is
2%.
